Cargando…
N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
Botulinum neurotoxin serotype A1 (BoNT/A1) is one of the most dangerous potential bioterrorism agents, and exerts its action by invading motoneurons. It is also a licensed drug widely used for medical and cosmetic applications. Here we report a 2.0 Å resolution crystal structure of BoNT/A1 receptor-...
Autores principales: | Yao, Guorui, Zhang, Sicai, Mahrhold, Stefan, Lam, Kwok-ho, Stern, Daniel, Bagramyan, Karine, Perry, Kay, Kalkum, Markus, Rummel, Andreas, Dong, Min, Jin, Rongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033645/ https://www.ncbi.nlm.nih.gov/pubmed/27294781 http://dx.doi.org/10.1038/nsmb.3245 |
Ejemplares similares
-
Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
por: Weisemann, Jasmin, et al.
Publicado: (2016) -
Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H
por: Yao, Guorui, et al.
Publicado: (2017) -
Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2
por: Liu, Zheng, et al.
Publicado: (2023) -
A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding
por: Yao, Guorui, et al.
Publicado: (2017) -
Botulinum Neurotoxin A Complex Recognizes Host Carbohydrates through Its Hemagglutinin Component
por: Yao, Guorui, et al.
Publicado: (2014)